ARES CAPITAL CORP (ARCC) - Q1 2021 Filing Summary
Business Context and Reporting Period
This summary covers the Form 10-Q for Ares Capital Corporation, a closed-end, non-diversified management investment company regulated as a Business Development Company (BDC). The reporting period is the three months ended March 31, 2021. The Company invests primarily in first and second lien senior secured loans, subordinated loans, and preferred equity in U.S. middle-market companies.
Key Financial Metrics
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Total Assets | $16,021 million | $16,196 million |
| Total Investments (Fair Value) | $15,429 million | $15,515 million |
| Net Investment Income | $144 million | $234 million |
| Net Increase in Stockholders' Equity (Operations) | $373 million | $(612) million |
| Net Income Per Share (Basic & Diluted) | $0.87 | $(1.42) |
| Net Assets Per Share | $17.45 | $16.97 |
| Total Debt Outstanding | $8,061 million | $8,582 million |
| Asset Coverage Ratio | 194% | N/A |
| Cash and Cash Equivalents | $337 million | $254 million |
Material Changes vs. Prior Period
- Profitability Reversal: The Company reported a net increase in stockholders' equity of $373 million in Q1 2021, a significant improvement from a net decrease of $612 million in Q1 2020. This turnaround was driven by a $272 million net realized and unrealized gain on investments in Q1 2021, compared to an $846 million loss in the prior year period.
- Net Investment Income Decline: Net investment income decreased to $144 million from $234 million year-over-year. This decline is primarily attributed to a $43 million realized loss on the extinguishment of debt (redemption of 2047 Notes) and higher total expenses ($241 million vs. $132 million), which included a $42 million capital gains incentive fee accrual under GAAP.
- Debt Reduction: Total debt outstanding decreased by approximately $521 million to $8,061 million. This reduction included the full redemption of $230 million in aggregate principal amount of the 2047 Notes in March 2021.
- Portfolio Composition: The portfolio remained diversified across industries, with Software & Services (15.3%) and Health Care Services (15.2%) representing the largest sectors by fair value.
Guidance, Outlook, and Risks
- Dividends: The Company declared a quarterly dividend of $0.40 per share, totaling $175 million, payable on March 31, 2021.
- Capital Markets Activity: In February 2021, the Company completed a public offering of 14.0 million shares, generating net proceeds of $249.4 million. The Company also has an authorized stock repurchase program with $500 million remaining available, though no repurchases were made in Q1 2021.
- Valuation Risks: Substantially all investments are valued using unobservable inputs (Level 3). The filing notes that fair values may fluctuate and differ from values realized in a forced liquidation. As of March 31, 2021, loans on non-accrual status represented 3.3% of total investments at amortized cost.
- Commitments: The Company has $1,597 million in net adjusted unfunded revolving and delayed draw loan commitments and $339 million in commitments to issue letters of credit.
Investor Verification Checklist
- Debt Extinguishment Impact: Verify the impact of the $43 million realized loss on the redemption of the 2047 Notes on the Company's liquidity and future interest expense.
- GAAP vs. Contractual Fees: Confirm the distinction between the $42 million GAAP accrual for capital gains incentive fees and the actual fees payable under the investment advisory agreement (which was $0 for the period).
- Non-Accrual Loans: Review the specific portfolio companies contributing to the 3.3% of loans on non-accrual status to assess credit risk concentration.
- Level 3 Valuations: Assess the sensitivity of the portfolio's fair value to changes in unobservable inputs, specifically market yields and EBITDA multiples, given that 99% of investments are Level 3.
- Unfunded Commitments: Monitor the $1.6 billion in unfunded commitments to ensure the Company maintains sufficient liquidity and borrowing capacity to meet funding obligations.